Article Information
History
- August 5, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Mona M. Almramhi, MSc1,2,*,
- Chris Finan, PhD3,4,5,
- Catherine S. Storm, BSc1,
- Amand F. Schmidt, PhD3,4,5,
- Demis A. Kia, MBBS1,
- Rachel Coneys, BSc6,
- Sandesh Chopade, MSc3,4,
- Aroon D. Hingorani, PhD, FRCP3,4,7 and
- Nicholas W. Wood, PhD, FRCP, FMedSci1,*
- 1Department of Clinical and Movement Neurosciences, University College London Queen Square Institute of Neurology, London, United Kingdom
- 2Faculty of Applied Medical Sciences, King Abdulaziz University, Kingdom of Saudi Arabia
- 3Institute of Cardiovascular Science, Faculty of Population Health, University College London, London, United Kingdom
- 4British Heart Foundation University College London Research Accelerator, London, United Kingdom
- 5Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, Utrecht, the Netherlands
- 6Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, United Kingdom
- 7Health Data Research UK London, University College London
- ↵*Correspondence: Nicholas W. Wood (n.wood{at}ucl.ac.uk), Mona M. Almramhi (m.almramhi{at}ucl.ac.uk, mmalmaramhi{at}kau.edu.sa)
Posted August 05, 2022.
Exploring the Role of Plasma Lipids and Statins Interventions on Multiple Sclerosis Risk and Severity: A Mendelian Randomization Study
